Although allogeneic hematopoietic stem cell transplantation (HSCT) can be curative for various hematological disorders, it continues to be associated with a significant incidence of treatment-related ...

A new study of more than 2,900 patients provides evidence that it's likely best to use as little corticosteroid medicine as possible when treating people who have lupus pericarditis, a common heart ...

In a recent study published in the Journal of the American College of Cardiology, researchers assessed the risk of myocarditis or pericarditis after the coronavirus disease 2019 (COVID-19) messenger ...

MSNBC anchor Yasmin Vossoughian recently spoke out about her diagnoses of the heart conditions pericarditis and myocarditis, both of which were brought on by a common cold. Vossoughian told Insider's ...

Until further studies are available to suggest otherwise, the routine use of colchicine in combination with other standard therapies for nonidiopathic pericarditis might be a reasonable treatment for ...

The disease usually starts as a fibrinous exudation with mycobacteria, polymorphonuclear cells and granuloma formation. The evolution is towards a serosanguineous exudate with lymphocytes, mononuclear ...

Myocarditis and pericarditis are conditions that involve heart inflammation. Myocarditis affects the heart muscle itself, while pericarditis impacts the pericardium — the layer of tissue that ...

A 28-year-old man who is new to your list, and whose records have not yet arrived, presents in your emergency surgery with a two-day history of substernal chest pain. He describes this as sharp and ...

Experiencing chest pain that doesn’t go away, shortness of breath, or the unsettling thump of a racing heartbeat can be frightening. For many, these signs may indicate pericarditis, a condition ...

This study and the accompanying editorial present important information that helps us compare and contrast acute pericarditis with AMI. Salisbury and colleagues attempted to determine the frequency of ...

HAMILTON, Bermuda, March 18, 2021 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio of assets designed to modulate immunological ...